MOA Life Plus Co. Ltd. (KOSDAQ:142760)
South Korea · Delayed Price · Currency is KRW 493.00
+5.00 (1.02%)
At close: Sep 11, 2026
MOA Life Plus Revenue
MOA Life Plus had revenue of 2.34B KRW in the quarter ending June 30, 2026, with 0.37% growth. This brings the company's revenue in the last twelve months to 10.46B, down -13.98% year-over-year. In the year 2025, MOA Life Plus had annual revenue of 11.22B, down -28.24%.
Revenue (ttm)
10.46B
Revenue Growth
-13.98%
P/S Ratio
0.99
Revenue / Employee
249.06M
Employees
42
Market Cap
10.39B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.22B | -4.41B | -28.24% |
| Dec 31, 2024 | 15.63B | -2.62B | -14.34% |
| Dec 31, 2023 | 18.25B | -3.76B | -17.08% |
| Dec 31, 2022 | 22.00B | -79.17B | -78.25% |
| Dec 31, 2021 | 101.17B | 20.72B | 25.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| NGeneBio | 41.80B |
| Eutilex.Co.,Ltd | 7.71B |
| Genotech | 7.28B |
| OLIPASS | 5.25B |
| Poongjeon Pharmacy CO.,LTD. | 1.54B |
| Quratis | 1.10B |
| Angiolab | 702.62M |
| Epibiotech | 449.62M |